Bone muscle interactions and vitamin D

Bone

Volumn 80, Issue , 2015, Pages 89-94

  Gunton, Jenny E ^a,b,c,d,e   Girgis, Christian M ^a,b,c,d   Baldock, Paul A ^b,e   Lips, Paul ^f  

^a University of Sydney   (Australia)

^b GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c WESTMEAD HOSPITAL   (Australia)

^d WESTMEAD HOSPITAL   (Australia)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

^f VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Bone; Cross talk; Muscle; Osteoporosis; Sarcopenia; Vitamin D

Indexed keywords

CALCIUM; INTERLEUKIN 6; MYOSTATIN; SCLEROSTIN; SOMATOMEDIN C; VASCULOTROPIN; VITAMIN D; VITAMIN D RECEPTOR;

BONE ATROPHY; BONE DEVELOPMENT; BONE INJURY; BONE MASS; BONE METABOLISM; CALCIUM METABOLISM; CHROMATIN IMMUNOPRECIPITATION; DISEASE ASSOCIATION; DISEASE SEVERITY; ELECTROMYOGRAPHY; HUMAN; META ANALYSIS (TOPIC); MOLECULAR INTERACTION; MUSCLE ATROPHY; MUSCLE DEVELOPMENT; MUSCLE MASS; MUSCULOSKELETAL DISEASE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RNA SEQUENCE; SIGNAL TRANSDUCTION; VITAMIN D DEFICIENCY; VITAMIN METABOLISM; VITAMIN SUPPLEMENTATION; ANIMAL; BONE; METABOLISM; OSTEOPOROSIS; SARCOPENIA; SKELETAL MUSCLE;

ANIMALS; BONE AND BONES; HUMANS; MUSCLE, SKELETAL; OSTEOPOROSIS; SARCOPENIA; VITAMIN D;

EID: 84943660496     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2015.02.029     Document Type: Review

References (82)

1. Abboud M., Puglisi D.A., Davies B.N., Rybchyn M., Whitehead N.P., Brock K.E., et al. Evidence for a specific uptake and retention mechanism for 25-hydroxyvitamin D (25OHD) in skeletal muscle cells. Endocrinology 2013, 154:3022-3030.
2. Girgis C.M., Mokbel N., Minn Cha K., Houweling P.J., Abboud M., Fraser D.R., et al. The vitamin D receptor (VDR) is expressed in skeletal muscle of male mice and modulates 25-hydroxyvitamin D (25OHD) uptake in myofibers. Endocrinology 2014, 155:3227-3237.
3. Connelly L., Woolf A., Brooks P. Cost-effectiveness of interventions for musculoskeletal conditions. Disease control in developing countries 2006, The International Bank for Reconstruction and Development/The World Bank, Washington DC. W. Bank (Ed.).
4. Rodríguez J.I., Palacios J., García-Alix A., Pastor I., Paniagua R. Effects of immobilization on fetal bone development. A morphometric study in newborns with congenital neuromuscular diseases with intrauterine onset. Calcif Tissue Int 1988, 43:335-339.
5. Rodríguez J., Garcia-Alix A., Palacios J., Paniagua R. Changes in the long bones due to fetal immobility caused by neuromuscular disease. A radiographic and histological study. J Bone Joint Surg 1988, 70:1052-1060.
6. DiGirolamo D.J., Kiel D.P., Esser K.A. Bone and skeletal muscle: neighbors with close ties. J Bone Miner Res 2013, 28:1509-1518. [Epub 2013/05/01].
7. Christoforidis A., Maniadaki I., Stanhope R. Growth hormone/insulin-like growth factor-1 axis during puberty. Pediatr Endocrinol Rev 2005, 3:5-10. [Epub 2005/12/22].
8. Girgis C., Mokbel N., Digirolamo D.J. Therapies for musculoskeletal disease: can we treat two birds with one stone?. Curr Osteoporos Rep 2014, 12:142-153. [Epub 2014/03/19].
9. Schweitzer R., Zelzer E., Volk T. Connecting muscles to tendons: tendons and musculoskeletal development in flies and vertebrates. Development 2010, 137:2807-2817. [Epub 2010/08/12].
10. Buckingham M., Vincent S.D. Distinct and dynamic myogenic populations in the vertebrate embryo. Curr Opin Genet Dev 2009, 19:444-453. [Epub 2009/09/19].
11. Zammit P.S., Heslop L., Hudon V., Rosenblatt J.D., Tajbakhsh S., Buckingham M.E., et al. Kinetics of myoblast proliferation show that resident satellite cells are competent to fully regenerate skeletal muscle fibers. Exp Cell Res 2002, 281:39-49. [Epub 2002/11/21].
12. Wang Y.X., Dumont N.A., Rudnicki M.A. Muscle stem cells at a glance. J Cell Sci 2014, 127:4543-4548.
13. Hawke T.J., Garry D.J. Myogenic satellite cells: physiology to molecular biology. J Appl Physiol 2001, 91:534-551.
14. Sambasivan R., Yao R., Kissenpfennig A., Van Wittenberghe L., Paldi A., Gayraud-Morel B., et al. Pax7-expressing satellite cells are indispensable for adult skeletal muscle regeneration. Development 2011, 138:3647-3656.
15. Seale P., Sabourin L.A., Girgis-Gabardo A., Mansouri A., Gruss P., Rudnicki M.A. Pax7 is required for the specification of myogenic satellite cells. Cell 2000, 102:777-786.
16. Nowlan N.C., Bourdon C., Dumas G., Tajbakhsh S., Prendergast P.J., Murphy P. Developing bones are differentially affected by compromised skeletal muscle formation. Bone 2010, 46:1275-1285. [Epub 2009/12/02].
17. Hamrick M.W. The skeletal muscle secretome: an emerging player in muscle-bone crosstalk. Bonekey Rep 2012, 1.
18. Harry L.E., Sandison A., Paleolog E.M., Hansen U., Pearse M.F., Nanchahal J. Comparison of the healing of open tibial fractures covered with either muscle or fasciocutaneous tissue in a murine model. Journal of orthopaedic research : official publication of the Orthopaedic Research Society 2008, 26(9):1238-1244.
19. Reverte M.M., Dimitriou R., Kanakaris N.K., Giannoudis P.V. What is the effect of compartment syndrome and fasciotomies on fracture healing in tibial fractures?. Injury 2011, 42(12):1402-1407.
20. Li Y.C., Pirro A.E., Amling M., Delling G., Baron R., Bronson R., et al. Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. Proc Natl Acad Sci U S A 1997, 94:9831-9835.
21. Johnson J.A., Grande J.P., Roche P.C., Kumar R. Ontogeny of the 1,25-dihydroxyvitamin D3 receptor in fetal rat bone. J Bone Miner Res 1996, 11:56-61. [Epub 1996/01/01].
22. Yoshizawa T., Handa Y., Uematsu Y., Takeda S., Sekine K., Yoshihara Y., et al. Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat Genet 1997, 16:391-396. [Epub 1997/08/01].
23. Endo I., Inoue D., Mitsui T., Umaki Y., Akaike M., Yoshizawa T., et al. Deletion of vitamin D receptor gene in mice results in abnormal skeletal muscle development with deregulated expression of myoregulatory transcription factors. Endocrinology 2003, 144:5138-5144. [Epub 2003/09/10].
24. Wikvall K. Cytochrome P450 enzymes in the bioactivation of vitamin D to its hormonal form (review). Int J Mol Med 2001, 7:201.
25. Lips P. Vitamin D, physiology. Prog Biophys Mol Biol 2006, 92:4-8.
26. Ding N., Liddle C., Evans R.M., Downes M. Hepatic actions of vitamin D receptor ligands: a sunshine option for chronic liver disease?. Expert Rev Clin Pharmacol 2013, 6:597-599.
27. Pike J.W., Lee S.M., Meyer M.B. Regulation of gene expression by 1,25-dihydroxyvitamin D in bone cells: exploiting new approaches and defining new mechanisms. Bonekey Rep 2014, 3:482. [Epub 2014/01/28].
28. Boland R. Role of vitamin D in skeletal muscle function. Endocr Rev 1986, 7:434-448. [Epub 1986/11/01].
29. Curry O.B., Basten J.F., Francis M.J., Smith R. Calcium uptake by sarcoplasmic reticulum of muscle from vitamin D-deficient rabbits. Nature 1974, 249:83-84. [Epub 1974/05/03].
30. ADVANCE_Collaborative Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. New Engl J Med 2008, 358:2560-2572.
31. Panda D.K., Miao D., Bolivar I., Li J., Huo R., Hendy G.N., et al. Inactivation of the 25-hydroxyvitamin D 1alpha-hydroxylase and vitamin D receptor demonstrates independent and interdependent effects of calcium and vitamin D on skeletal and mineral homeostasis. J Biol Chem 2004, 279:16754-16766. [Epub 2004/01/24].
32. Gardiner E.M., Baldock P.A., Thomas G.P., Sims N.A., Henderson N.K., Hollis B., et al. Increased formation and decreased resorption of bone in mice with elevated vitamin D receptor in mature cells of the osteoblastic lineage. FASEB J 2000, 14:1908-1916.
33. Lam N.N., Triliana R., Sawyer R.K., Atkins G.J., Morris H.A., O'Loughlin P.D., et al. Vitamin D receptor overexpression in osteoblasts and osteocytes prevents bone loss during vitamin D-deficiency. J Steroid Biochem Mol Biol 2014, 144(A):128-131. [Epub 2014/01/18].
34. Anderson P.H., Lam N.N., Turner A.G., Davey R.A., Kogawa M., Atkins G.J., et al. The pleiotropic effects of vitamin D in bone. J Steroid Biochem Mol Biol 2013, 136:190-194. [Epub 2012/09/18].
35. Yamamoto Y., Yoshizawa T., Fukuda T., Shirode-Fukuda Y., Yu T., Sekine K., et al. Vitamin d receptor in osteoblasts is a negative regulator of bone mass control. Endocrinology 2013, 154:1008-1020. [Epub 2013/02/08].
36. Shi Y.-c., Worton L., Esteban L., Baldock P., Fong C., Eisman J.A., et al. Effects of continuous activation of vitamin D and Wnt response pathways on osteoblastic proliferation and differentiation. Bone 2007, 41:87-96.
37. van Lierop A., Hamdy N., van Bezooijen R., Löwik C., Papapoulos S. The role of sclerostin in the pathophysiology of sclerosing bone dysplasias. Clin Rev Bone Miner Metab 2012, 10:108-116.
38. Lieben L., Masuyama R., Torrekens S., Van Looveren R., Schrooten J., Baatsen P., et al. Normocalcemia is maintained in mice under conditions of calcium malabsorption by vitamin D-induced inhibition of bone mineralization. J Clin Invest 2012, 122:1803-1815.
39. Takeda S., Yoshizawa T., Nagai Y., Yamato H., Fukumoto S., Sekline K., et al. Stimulation of osteoclast formation by 1, 25-dihydroxyvitamin D requires its binding to vitamin D receptor (VDR) in osteoblastic cells: studies using VDR knockout mice. Endocrinology 1999, 140:1005-1008.
40. Girgis C.M., Clifton-Bligh R.J., Hamrick M.W., Holick M.F., Gunton J.E. The roles of vitamin D in skeletal muscle: form, function and metabolism. Endocr Rev 2013, 34:33-83.
41. Girgis C.M., Clifton-Bligh R.J., Turner N., Lau S.L., Gunton J.E. Effects of vitamin D in skeletal muscle: falls, strength, athletic performance and insulin sensitivity. Clin Endocrinol (Oxf) 2014, 80:169-181.
42. Wicherts I.S., van Schoor N.M., Boeke A.J., Visser M., Deeg D.J., Smit J., et al. Vitamin D status predicts physical performance and its decline in older persons. J Clin Endocrinol Metab 2007, 92:2058-2065. [Epub 2007/03/08].
43. Sohl E., de Jongh R., Heijboer A., Swart K., Brouwer-Brolsma E., Enneman A., et al. Vitamin D status is associated with physical performance: the results of three independent cohorts. Osteoporos Int 2013, 24:187-196.
44. Need A.G., O'Loughlin P.D., Morris H.A., Coates P.S., Horowitz M., Nordin B. Vitamin D metabolites and calcium absorption in severe vitamin D deficiency. J Bone Miner Res 2008, 23:1859-1863.
45. Bischoff-Ferrari H.A., Dawson-Hughes B., Staehelin H.B., Orav J.E., Stuck A.E., Theiler R., et al. Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ (Clin Res Ed) 2009, 339:b3692. [Epub 2009/10/03].
46. Kaji H. Interaction between muscle and bone. J Bone Metab 2014, 21:29-40.
47. Onder G., Capoluongo E., Danese P., Settanni S., Russo A., Concolino P., et al. Vitamin D receptor polymorphisms and falls among older adults living in the community: results from the ilSIRENTE study. J Bone Miner Res 2008, 23:1031-1036. [Epub 2008/02/28].
48. Roth S.M., Zmuda J.M., Cauley J.A., Shea P.R., Ferrell R.E. Vitamin D receptor genotype is associated with fat-free mass and sarcopenia in elderly men. J Gerontol A Biol Sci Med Sci 2004, 59:10-15. [Epub 2004/01/14].
49. Visser M., Deeg D.J., Lips P. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab 2003, 88:5766-5772. [Epub 2003/12/13].
50. White T.A., LeBrasseur N.K. Myostatin and sarcopenia: opportunities and challenges-a mini-review. Gerontology 2014, 60:289-293.
51. Kellum E., Starr H., Arounleut P., Immel D., Fulzele S., Wenger K., et al. Myostatin (GDF-8) deficiency increases fracture callus size, Sox-5 expression, and callus bone volume. Bone 2009, 44:17-23.
52. Hamrick M., Shi X., Zhang W., Pennington C., Thakore H., Haque M., et al. Loss of myostatin (GDF8) function increases osteogenic differentiation of bone marrow-derived mesenchymal stem cells but the osteogenic effect is ablated with unloading. Bone 2007, 40:1544-1553.
53. Tanaka K.-i., Kanazawa I., Yamaguchi T., Yano S., Kaji H., Sugimoto T. Active vitamin D possesses beneficial effects on the interaction between muscle and bone. Biochem Biophys Res Commun 2014, 450:482-487.
54. Ceglia L. Vitamin D, and skeletal muscle tissue and function. Mol Aspects Med 2008, 29:407-414. [Epub 2008/08/30].
55. Girgis C.M., Clifton-Bligh R.J., Mokbel N., Cheng K., Gunton J.E. Vitamin D signaling regulates proliferation, differentiation and myotube size in C2C12 skeletal muscle cells. Endocrinology 2014, 155:347-357.
56. Girgis C.M., Mokbel N., Minn Cha K., Houweling P.J., Abboud M., Fraser D.R., et al. The vitamin D receptor (VDR) is expressed in skeletal muscle of male mice and modulates 25-hydroxyvitamin D (25OHD) uptake in myofibers. Endocrinology 2014, en20141016. [Epub 2014/06/21].
57. Sato Y., Iwamoto J., Kanoko T., Satoh K. Low-dose vitamin D prevents muscular atrophy and reduces falls and hip fractures in women after stroke: a randomized controlled trial. Cerebrovasc Dis 2005, 20:187-192. [Epub 2005/08/10].
58. Sorensen O.H., Lund B., Saltin B., Andersen R.B., Hjorth L., Melsen F., et al. Myopathy in bone loss of ageing: improvement by treatment with 1 alpha-hydroxycholecalciferol and calcium. Clin Sci 1979, 56:157-161. [Epub 1979/02/01].
59. Schubert L., DeLuca H.F. Hypophosphatemia is responsible for skeletal muscle weakness of vitamin D deficiency. Arch Biochem Biophys 2010, 500:157-161. [Epub 2010/06/03].
60. Yeap B.B., Divitini M.L., Gunton J.E., Olynyk J.K., Beilby J.P., McQuillan B., et al. Higher ferritin levels, but not serum iron or transferrin saturation, are associated with type 2 diabetes mellitus in adult men and women free of genetic haemochromatosis. Clin Endocrinol (Oxf) 2015, 82(4):525-532.
61. Girgis C.M., Lau S.L., Clifton-Bligh R.J., Gunton J.E. Direct effects of VDR ablation on bone mass. Re: Vitamin D receptor in osteoblasts is a negative regulator of bone mass control (research letter in response to Yamamoto et al.). Endocrinology 2013, 154. [Online only].
62. Garcia L.A., King K.K., Ferrini M.G., Norris K.C., Artaza J.N. 1,25(OH)2vitamin D3 stimulates myogenic differentiation by inhibiting cell proliferation and modulating the expression of promyogenic growth factors and myostatin in C2C12 skeletal muscle cells. Endocrinology 2011, 152:2976-2986. [Epub 2011/06/16].
63. Elkasrawy M.N., Hamrick M.W. Myostatin (GDF-8) as a key factor linking muscle mass and skeletal form. J Musculoskelet Neuronal Interact 2010, 10:56.
64. Lips P., Bouillon R., Jongen M., Van Ginkel F., Van der Vijgh W., Netelenbos J. The effect of trauma on serum concentrations of vitamin D metabolites in patients with hip fracture. Bone 1985, 6:63-67.
65. Barker T., Henriksen V.T., Martins T.B., Hill H.R., Kjeldsberg C.R., Schneider E.D., et al. Higher serum 25-hydroxyvitamin D concentrations associate with a faster recovery of skeletal muscle strength after muscular injury. Nutrients 2013, 5:1253-1275. [Epub 2013/04/19].
66. Srikuea R., Zhang X., Park-Sarge O.K., Esser K.A. VDR and CYP27B1 are expressed in C2C12 cells and regenerating skeletal muscle: potential role in suppression of myoblast proliferation. Am J Physiol Cell Physiol 2012, 303:C396-C405. [Epub 2012/06/01].
67. Stratos I., Li Z., Herlyn P., Rotter R., Behrendt A.K., Mittlmeier T., et al. Vitamin D increases cellular turnover and functionally restores the skeletal muscle after crush injury in rats. Am J Pathol 2013, 182:895-904. [Epub 2012/12/25].
68. Girgis CM Abstract HP, Mokbel N, Cha KM, Lalwani A, Downes MR, Clifton-Bligh R, Gunton JE. The Vitamin D Receptor (VDR) is Expressed in Murine Skeletal Muscle and Modulates Regeneration at this site US Endocrine Society Meeting, Chicago USA, Abstract MON-02372014.
69. Barker T., Schneider E.D., Dixon B.M., Henriksen V.T., Weaver L.K. Supplemental vitamin D enhances the recovery in peak isometric force shortly after intense exercise. Nutr Metab (Lond) 2013, 10:69. [Epub 2013/12/10].
70. Choi M., Park H., Cho S., Lee M. Vitamin D3 supplementation modulates inflammatory responses from the muscle damage induced by high-intensity exercise in SD rats. Cytokine 2013, 63:27-35. [Epub 2013/05/15].
71. Garcia L.A., Ferrini M.G., Norris K.C., Artaza J.N. 1,25(OH)(2)vitamin D(3) enhances myogenic differentiation by modulating the expression of key angiogenic growth factors and angiogenic inhibitors in C(2)C(12) skeletal muscle cells. J Steroid Biochem Mol Biol 2013, 133:1-11. [Epub 2012/09/18].
72. Ding N., Yu R.T., Subramaniam N., Sherman M.H., Wilson C., Rao R., et al. A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response. Cell 2013, 153:601-613. [Epub 2013/04/30].
73. Gannage-Yared M.H., Azoury M., Mansour I., Baddoura R., Halaby G., Naaman R. Effects of a short-term calcium and vitamin D treatment on serum cytokines, bone markers, insulin and lipid concentrations in healthy post-menopausal women. J Endocrinol Invest 2003, 26:748-753.
74. Juffer P., Jaspers R.T., Lips P., Bakker A.D., Klein-Nulend J. Expression of muscle anabolic and metabolic factors in mechanically loaded MLO-Y4 osteocytes. Am J Physiol Endocrinol Metab 2012, 302:E389-E395.
75. Lalwani A., Stokes R.A., Lau S.M., Gunton J.E. Deletion of ARNT (aryl hydrocarbon receptor nuclear translocator) in β-cells causes islet transplant failure with impaired β-cell function. PLoS One 2014, 9:e98435.
76. Spatz J., Fields E., Yu E., Pajevic P.D., Bouxsein M., Sibonga J., et al. Serum sclerostin increases in healthy adult men during bed rest. J Clin Endocrinol Metab 2012, 97:E1736-E1740.
77. Dawson-Hughes B., Harris S.S., Ceglia L., Palermo N.J. Effect of supplemental vitamin D and calcium on serum sclerostin levels. Eur J Endocrinol 2014, 170:645-650.
78. Sherman M.H., Yu R.T., Engle D.D., Ding N., Atkins A.R., Tiriac H., et al. Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy. Cell 2014, 159:80-93.
79. Van Driel M., Koedam M., Buurman C., Roelse M., Weyts F., Chiba H., et al. Evidence that both 1α, 25dihydroxyvitamin D3 and 24hydroxylated D3 enhance human osteoblast differentiation and mineralization. J Cell Biochem 2006, 99:922-935.
80. Yang D., Atkins G.J., Turner A.G., Anderson P.H., Morris H.A. Differential effects of 1, 25-dihydroxyvitamin D on mineralisation and differentiation in two different types of osteoblast-like cultures. J Steroid Biochem Mol Biol 2013, 136:166-170.
81. Ettehad H., Mirbolook A., Mohammadi F., Mousavi M., Ebrahimi H., Shirangi A. Changes in the serum level of vitamin d during healing of tibial and femoral shaft fractures. Trauma Mon 2014, 19:e10946. [Epub 2014/04/11].
82. Seo E.G., Norman A.W. Threefold induction of renal 25-hydroxyvitamin D3-24-hydroxylase activity and increased serum 24,25-dihydroxyvitamin D3 levels are correlated with the healing process after chick tibial fracture. J Bone Miner Res 1997, 12:598-606. [Epub 1997/04/01].